Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cited by (1,048)

Items 201–300 of 1,048

1. A systematic review of SARS-CoV-2 vaccine candidates
   Yetian Dong, Tong Dai, Yujun Wei, Long Zhang, Min Zheng, Fangfang Zhou · 2020 · Signal Transduction and Targeted Therapy
2. The Impact of COVID-19 Disease on Platelets and Coagulation
   Geoffrey D. Wool, Jonathan L Miller · 2020 · Pathobiology
3. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
   Omna Sharma, Ali A. Sultan, Hong Ding, Chris R. Triggle · 2020 · Frontiers in Immunology
4. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
   Stuart Phillip Weisberg, Thomas J. Connors, Yun Zhu, Matthew R. Baldwin, Wen-Hsuan Wendy Lin, Sandeep N. Wontakal, Peter Anthony Szabo, Steven B. Wells, Pranay Dogra, Joshua I. Gray et al. · 2020 · Nature Immunology
5. SARS-CoV-2 spike D614G change enhances replication and transmission
   Zhou, Bin, Thao, Tran Thi Nhu, Hoffmann, Donata, Taddeo, Adriano, Ebert, Nadine, Labroussaa, Fabien, Pohlmann, Anne, King, Jacqueline, Steiner, Silvio, Kelly, Jenna N. et al. · 2021 · Nature
6. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
   Samuel James Brake, Kathryn Barnsley, Wenying Lu, Kielan Darcy McAlinden, Mathew Suji Eapen, Sukhwinder Singh Sohal · 2020 · Journal of Clinical Medicine
7. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
   McCallum, Matthew, Czudnochowski, Nadine, Rosen, Laura E., Zepeda, Samantha K., Bowen, John E., Walls, Alexandra C., Hauser, Kevin, Joshi, Anshu, Stewart, Cameron, Dillen, Josh R. et al. · 2022 · Science
8. Kinetics of viral load and antibody response in relation to COVID-19 severity
   Yanqun Wang, Lu Zhang, Ling Sang, Ye Feng, Shicong Ruan, Bei Zhong, Tie Song, Abeer N. Alshukairi, Rongchang Chen, Zhaoyong Zhang et al. · 2020 · Journal of Clinical Investigation
9. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
   Walls, Alexandra C., Fiala, Brooke, Schäfer, Alexandra, Wrenn, Samuel, Pham, Minh N., Murphy, Michael, Tse, Longping V., Shehata, Laila, O’Connor, Megan A., Chen, Chengbo et al. · 2020 · Cell
10. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
    Subramanian Boopathi, Adolfo B. Poma, Ponmalai G. Kolandaivel · 2020 · Journal of Biomolecular Structure and Dynamics
11. Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
    Pegu, Amarendra, O’Connell, Sarah E., Schmidt, Stephen D., O’Dell, Sijy, Talana, Chloe A., Lai, Lilin, Albert, Jim, Anderson, Evan, Bennett, Hamilton, Corbett, Kizzmekia S. et al. · 2021 · Science
12. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
    Maria Romanò, Alessia Ruggiero, Flavia Squeglia, Giovanni Maga, Rita Berisio · 2020 · Cells
13. Broad neutralization of SARS-related viruses by human monoclonal antibodies
    Anna Z. Wec, Daniel Wrapp, Andrew S. Herbert, Daniel P. Maurer, Denise Haslwanter, Mrunal Sakharkar, Rohit K. Jangra, M. Eugenia Dieterle, Asparouh Lilov, Deli Huang et al. · 2020 · Science
14. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
    Cerutti, Gabriele, Guo, Yicheng, Zhou, Tongqing, Gorman, Jason, Lee, Myungjin, Rapp, Micah, Reddem, Eswar R., Yu, Jian, Bahna, Fabiana, Bimela, Jude et al. · 2021 · Cell Host & Microbe
15. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells
    Sarah Temmam, Khamsing Vongphayloth, Eduard Baquero, Sandie Munier, Massimiliano Bonomi, Béatrice Regnault, Bounsavane Douangboubpha, Yasaman Karami, Delphine Chrétien, Daosavanh Sanamxay et al. · 2022 · Nature
16. The molecular virology of coronaviruses
    Ella Hartenian, Divya Nandakumar, Azra Lari, Michael Ly, Jessica M. Tucker, Britt A. Glaunsinger · 2020 · Journal of Biological Chemistry
17. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
    Tortorici, M. Alejandra, Beltramello, Martina, Lempp, Florian A., Pinto, Dora, Dang, Ha V., Rosen, Laura E., McCallum, Matthew, Bowen, John, Minola, Andrea, Jaconi, Stefano et al. · 2020 · Science
18. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
    Suthar, Mehul S., Zimmerman, Matthew G., Kauffman, Robert C., Mantus, Grace, Linderman, Susanne L., Hudson, William H., Vanderheiden, Abigail, Nyhoff, Lindsay, Davis, Carl W., Adekunle, Oluwaseyi et al. · 2020 · Cell Reports Medicine
19. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
    Tian, Jing-Hui, Patel, Nita, Haupt, Robert, Zhou, Haixia, Weston, Stuart, Hammond, Holly, Logue, James, Portnoff, Alyse D., Norton, James, Guebre-Xabier, Mimi et al. · 2021 · Nature Communications
20. The many faces of the anti-COVID immune response
    Santosha Adipudi Vardhana, Jedd D. Wolchok · 2020 · The Journal of Experimental Medicine
21. The dawn of mRNA vaccines: the COVID-19 case
    Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Dewitte, Heleen · 2021 · Journal of Controlled Release
22. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico
    Omar Yaxmehen Bello‐Chavolla, Jessica Paola Bahena-López, Neftali Eduardo Antonio‐Villa, Arsenio Vargas‐Vázquez, Armando González-Díaz, Alejandro Márquez‐Salinas, Carlos A. Fermín‐Martínez, J. Jesús Naveja, Carlos Alberto Aguilar-Salinas · 2020 · The Journal of Clinical Endocrinology & Metabolism
23. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning
    Ong, Edison, Wong, Mei U, Huffman, Anthony, He, Yongqun · 2020 · Frontiers in Immunology
24. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
    Bayati, Armin, Kumar, Rahul, Francis, Vincent, McPherson, Peter S. · 2021 · Journal of Biological Chemistry
25. Algorithm for optimized mRNA design improves stability and immunogenicity
    Zhang, He, Zhang, Liang, Lin, Ang, Xu, Congcong, Li, Ziyu, Liu, Kaibo, Liu, Boxiang, Ma, Xiaopin, Zhao, Fanfan, Jiang, Huiling et al. · 2023 · Nature
26. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process
    Zhang, Hao, Kang, Zijian, Gong, Haiyi, Xu, Da, Wang, Jing, Li, Zhixiu, Li, Zifu, Cui, Xinggang, Xiao, Jianru, Zhan, Jian et al. · 2020 · Gut
27. Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 ( Covid ‐19)
    Yue Zhou, Jingwei Chi, Wenshan Lv, Yangang Wang · 2020 · Diabetes/Metabolism Research and Reviews
28. Assessing the relationship between surface levels of PM2.5 and PM10 particulate matter impact on COVID-19 in Milan, Italy
    Maria A. Zoran, Roxana Savastru, Dan M. Savastru, Marina N. Tautan · 2020 · The Science of The Total Environment
29. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
    Abdurrahman Tufan, Aslıhan Avanoğlu Güler, Marco Matucci‐Cerinic · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
30. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
    Balamurugan Shanmugaraj, Konlavat Siriwattananon, Kittikhun Wangkanont, Waranyoo Phoolcharoen · 2020 · Asian Pacific Journal of Allergy and Immunology
31. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
    Shuai Wang, Zongyang Qiu, Yingnan Hou, Xiya Deng, Wei Xu, Tingting Zheng, Peihan Wu, Shaofang Xie, Weixiang Bian, Chong Zhang et al. · 2021 · Cell Research
32. Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop
    Javier A. Jaimes, Nicole M. André, Joshua S. Chappie, Jean K. Millet, Gary R. Whittaker · 2020 · Journal of Molecular Biology
33. A perspective on potential antibody-dependent enhancement of SARS-CoV-2
    Arvin, Ann M., Fink, Katja, Schmid, Michael A., Cathcart, Andrea, Spreafico, Roberto, Havenar-Daughton, Colin, Lanzavecchia, Antonio, Corti, Davide, Virgin, Herbert W. · 2020 · Nature
34. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
    Jiandong Huo, Audrey Le Bas, Reinis R. Ruza, Helen M. E. Duyvesteyn, Halina Mikolajek, Tomas Malinauskas, Tiong Kit Tan, Pramila Rijal, Maud Dumoux, Philip N. Ward et al. · 2020 · Nature Structural & Molecular Biology
35. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
    Zeinab Abdelrahman, Mengyuan Li, Xiaosheng Wang · 2020 · Frontiers in Immunology
36. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
    Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiaoxia Lü, Yaguang Zhang, Liyang Ma, Wangpeng Gu et al. · 2020 · Cellular and Molecular Immunology
37. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
    Christian Albert Devaux, Jean‐Marc Rolain, Didier Raoult · 2020 · Journal of Microbiology Immunology and Infection
38. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
    Bajaj, Varnica, Gadi, Nirupa, Spihlman, Allison P., Wu, Samantha C., Choi, Christopher H., Moulton, Vaishali R. · 2021 · Frontiers in Physiology
39. Enhanced SARS-CoV-2 neutralization by dimeric IgA
    Wang, Zijun, Lorenzi, Julio C. C., Muecksch, Frauke, Finkin, Shlomo, Viant, Charlotte, Gaebler, Christian, Cipolla, Melissa, Hoffmann, Hans-Heinrich, Oliveira, Thiago Y., Oren, Deena A. et al. · 2021 · Science Translational Medicine
40. Coronavirus disease 2019 (COVID-19): a clinical update
    Min Zhou, Xinxin Zhang, Jieming Qu · 2020 · Frontiers of Medicine
41. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
    Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi · 2020 · Glycobiology
42. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
    Baoqing Sun, Ying Feng, Xiaoneng Mo, Peiyan Zheng, Qian Wang, Pingchao Li, Ping Peng, Xiaoqing Liu, Zhilong Chen, Huimin Huang et al. · 2020 · Emerging Microbes & Infections
43. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
    Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, Dipyaman Ganguly, Samit Chattopadhyay · 2020 · Frontiers in Immunology
44. Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
    Mingxuan Xie, Qiong Chen · 2020 · International Journal of Infectious Diseases
45. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019
    Peter D. Burbelo, Francis X. Riedo, Chihiro Morishima, Stephen A. Rawlings, Davey M. Smith, Sanchita Das, Jeffrey R. Strich, Daniel S. Chertow, Richard T. Davey, Jeffrey I. Cohen · 2020 · The Journal of Infectious Diseases
46. Mutations Strengthened SARS-CoV-2 Infectivity
    Jiahui Chen, Rui Wang, Menglun Wang, Guo‐Wei Wei · 2020 · Journal of Molecular Biology
47. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
    Davidson, Andrew D., Williamson, Maia Kavanagh, Lewis, Sebastian, Shoemark, Deborah, Carroll, Miles W., Heesom, Kate J., Zambon, Maria, Ellis, Joanna, Lewis, Philip A., Hiscox, Julian A. et al. · 2020 · Genome Medicine
48. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
    Röltgen, Katharina, Powell, Abigail E., Wirz, Oliver F., Stevens, Bryan A., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Wang, Hannah, Sahoo, Malaya K., Huang, ChunHong et al. · 2020 · Science Immunology
49. Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV‑2 Spike Glycoprotein
    Yanling Song, Jia Tao Song, Xinyu Wei, Mengjiao Huang, Miao Sun, Lin Zhu, Bingqian Lin, Haicong Shen, Zhi Zhu, Chaoyong James Yang · 2020 · Analytical Chemistry
50. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
    Changhai Lei, Kewen Qian, Li Tian, Sheng Zhang, Wenyan Fu, Min Ding, Shi Hu · 2020 · Nature Communications
51. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
    Xiao, Wenjing, Jiang, Wenjie, Chen, Zheng, Huang, Yu, Mao, Junyi, Zheng, Wei, Hu, Yonghe, Shi, Jianyou · 2025 · Signal Transduction and Targeted Therapy
52. COVID-19: Drug Targets and Potential Treatments
    Carmen Gil, Tiziana Ginex, Inés Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria Eugenia Campillo et al. · 2020 · Journal of Medicinal Chemistry
53. The hallmarks of COVID-19 disease
    Daolin Tang, Paul Burdett Comish, Rui Kang · 2020 · PLoS Pathogens
54. The first 12 months of COVID-19: a timeline of immunological insights
    Thiago Carvalho, Florian Krammer, Akiko Iwasaki · 2021 · Nature reviews. Immunology
55. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
    DANIEL C. BATLLE, Jan A Wysocki, K.J.F. Satchell · 2020 · Clinical Science
56. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
    Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch et al. · 2020 · Cell Host & Microbe
57. A Global Review on Short Peptides: Frontiers and Perspectives
    Vasso Apostolopoulos, Joanna Bojarska, Tsun‐Thai Chai, Sherif M. Elnagdy, Krzysztof Kaczmarek, John Matsoukas, Roger R. C. New, Keykavous Parang, Octavio Paredes‐López, Hamideh Parhiz et al. · 2021 · Molecules
58. Sustainable Personal Protective Clothing for Healthcare Applications: A Review
    Nazmul Karim, Shaila Afroj, Kate Lloyd, Laura Clarke Oaten, Daria V. Andreeva, Chris Carr, Andrew D. Farmery, Il‐Doo Kim, Kostya S. Novoselov · 2020 · ACS Nano
59. COVID-19 and multiorgan failure: A narrative review on potential mechanisms
    Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, Babak Ebrahimi, Atousa Yarahmadi, Ghomareza Hassanzadeh · 2020 · Journal of Molecular Histology
60. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
    Jiří Zahradník, Shir Marciano, Maya Shemesh, Eyal Zoler, Daniel Harari, Jeanne Chiaravalli, Bjoern Meyer, Yinon Rudich, Chunlin Li, Ira Marton et al. · 2021 · Nature Microbiology
61. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
    Juno, Jennifer A., Tan, Hyon-Xhi, Lee, Wen Shi, Reynaldi, Arnold, Kelly, Hannah G., Wragg, Kathleen, Esterbauer, Robyn, Kent, Helen E., Batten, C. Jane, Mordant, Francesca L. et al. · 2020 · Nature Medicine
62. Neurological Manifestations of COVID‐19: A systematic review and current update
    Abigail Whittaker, Matthew Anson, Amer Harky · 2020 · Acta Neurologica Scandinavica
63. An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
    Michael Schoof, Bryan Faust, Reuben A. Saunders, Smriti Sangwan, Veronica V. Rezelj, Nick Hoppe, Morgane Boone, Christian B. Billesbølle, Cristina Puchades, Caleigh M. Azumaya et al. · 2020 · Science
64. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
    Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, James Brett Case, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Elaine C. Chen et al. · 2020 · Nature Medicine
65. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein
    Christine Toelzer, Kapil Gupta, Sathish K.N. Yadav, Ufuk Borucu, Andrew D. Davidson, Maia Kavanagh Williamson, Deborah K. Shoemark, Frédéric Garzoni, Oskar Staufer, Rachel Milligan et al. · 2020 · Science
66. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study
    Chao Gao, Yue Cai, Kan Zhang, Lei Zhou, Yao Zhang, Xijing Zhang, Qi Li, Weiqin Li, Shiming Yang, Xiaoyan Zhao et al. · 2020 · European Heart Journal
67. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
    McCallum, Matthew, Bassi, Jessica, De Marco, Anna, Chen, Alex, Walls, Alexandra C., Di Iulio, Julia, Tortorici, M. Alejandra, Navarro, Mary-Jane, Silacci-Fregni, Chiara, Saliba, Christian et al. · 2021 · Science
68. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
    Case, James Brett, Rothlauf, Paul W., Chen, Rita E., Liu, Zhuoming, Zhao, Haiyan, Kim, Arthur S., Bloyet, Louis-Marie, Zeng, Qiru, Tahan, Stephen, Droit, Lindsay et al. · 2020 · Cell Host & Microbe
69. Controlling the SARS-CoV-2 spike glycoprotein conformation
    Rory C. Henderson, Robert J. Edwards, Katayoun Mansouri, Katarzyna Janowska, Victoria Stalls, S. Gobeil, Megan Kopp, Dapeng Li, Robert Parks, Allen L. Hsu et al. · 2020 · Nature Structural & Molecular Biology
70. The emergence, genomic diversity and global spread of SARS-CoV-2
    Juan Li, Shengjie Lai, George F. Gao, Weifeng Shi · 2021 · Nature
71. The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
    Noton Kumar Dutta, Kaushiki Mazumdar, James T. Gordy · 2020 · Journal of Virology
72. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
    Zhen Cui, Pan Liu, Nan Wang, Lei Wang, Kaiyue Fan, Qianhui Zhu, Kang Wang, Ruihong Chen, Rui Feng, Zijing Jia et al. · 2022 · Cell
73. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
    Hong-Long Ji, Runzhen Zhao, Sadis Matalon, Michael A. Matthay · 2020 · Physiological Reviews
74. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
    Liangwei Duan, Qianqian Zheng, Hongxia Zhang, Yuna Niu, Yunwei Lou, Hui Wang · 2020 · Frontiers in Immunology
75. Structural impact on SARS-CoV-2 spike protein by D614G substitution
    Jun Zhang, Yongfei Cai, Tianshu Xiao, Jianming Lu, Hanqin Peng, Sarah M. Sterling, Richard M. Walsh, Sophia Rits‐Volloch, Haisun Zhu, Alec N. Woosley et al. · 2021 · Science
76. In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
    Bhumi M. Shah, Palmi Modi, Sneha R. Sagar · 2020 · Life Sciences
77. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
    Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, Alan Valaperti, Jens Schreiner, Aline Wolfensberger, Miro E. Raeber, Sarah Adamo, Sebastian Weigang, Marc Emmenegger et al. · 2020 · Journal of Allergy and Clinical Immunology
78. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Donato Gemmati, Barbara Bramanti, Maria Luisa Serino, Paola Secchiero, Giorgio Zauli, Veronica Tisato · 2020 · International Journal of Molecular Sciences
79. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
    Huibin Lv, Nicholas C. Wu, Owen Tak-Yin Tsang, Meng Yuan, Ranawaka A. P. M. Perera, Wai-Shing Leung, Ray T. Y. So, Jacky Man Chun Chan, Garrick K. Yip, Thomas Shiu‐Hong Chik et al. · 2020 · Cell Reports
80. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID‐19): A Chinese perspective
    Yu Kyeong Han, Hailan Yang · 2020 · Journal of Medical Virology
81. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study
    Mengmeng Li, Liang Chen, Jingxiao Zhang, Chenglong Xiong, Xiangjie Li · 2020 · PLoS ONE
82. COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese–Western Medicine for the Management of 2019 Novel Coronavirus Disease
    Kam Wa Chan, Vivian Taam Wong, Sydney C.W. Tang · 2020 · The American Journal of Chinese Medicine
83. Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
    Yufei Xiang, Sham Nambulli, Zhengyun Xiao, Heng Liu, Zhe Sang, William Paul Duprex, Dina Schneidman‐Duhovny, Cheng Zhang, Yi Shi · 2020 · Science
84. Saliva: potential diagnostic value and transmission of 2019-nCoV
    Ruoshi Xu, Bomiao Cui, Xiaobo Duan, Ping Zhang, Xuedong Zhou, Quan Yuan · 2020 · International Journal of Oral Science
85. Emergence of SARS-CoV-2 through recombination and strong purifying selection
    Xiaojun Li, Elena E. Giorgi, Manukumar Honnayakanahalli Marichannegowda, Brian Thomas Foley, Chuan Xiao, Xiang‐Peng Kong, Yue Chen, Sandrasegaram Gnanakaran, Bette Korber, Feng Gao · 2020 · Science Advances
86. COVID-19 pandemic—a focused review for clinicians
    Müge Çevik, Connor Bamford, Antonia Ying Wai Ho · 2020 · Clinical Microbiology and Infection
87. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
    Mary Hongying Cheng, She Zhang, Rebecca A. Porritt, Magali Noval Rivas, Lisa Paschold, Edith Willscher, Mascha Binder, Moshe Arditi, İvet Bahar · 2020 · Proceedings of the National Academy of Sciences
88. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis
    Xinhui Wang, Xuexian Fang, Zhaoxian Cai, Xiaotian Wu, Xiaotong Gao, Junxia Min, Fudi Wang · 2020 · Research
89. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
    Sairaj Satarker, Madhavan Nampoothiri · 2020 · Archives of Medical Research
90. CoV-AbDab: the coronavirus antibody database
    Raybould, Matthew I J, Kovaltsuk, Aleksandr, Marks, Claire, Deane, Charlotte M · 2021 · Bioinformatics
91. Nanotechnology for COVID-19: Therapeutics and Vaccine Research
    Gaurav Chauhan, Marc Jozef Madou, Sourav Kalra, Vianni Chopra, Deepa Ghosh, Sergio Omar Martinez-Chapa · 2020 · ACS Nano
92. Broad betacoronavirus neutralization by a stem helix–specific human antibody
    Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Jun Siong Low, M. Alejandra Tortorici, Michael Patrick Housley, Julia Noack, Alexandra C. Walls, John E. Bowen, Barbara Guarino et al. · 2021 · Science
93. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
    Chek Meng Poh, Guillaume Carissimo, Bei Wang, Siti Naqiah Amrun, Cheryl Yi‐Pin Lee, Rhonda Sin‐Ling Chee, Siew‐Wai Fong, Nicholas Kim‐Wah Yeo, Wen-Hsin Lee, Anthony Torres‐Ruesta et al. · 2020 · Nature Communications
94. Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV‑2
    Yanxiao Han, Petr Král · 2020 · ACS Nano
95. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
    Yanwei Li, Wei Zhou, Yang Li, Ran You · 2020 · Pharmacological Research
96. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM
    Cong Xu, Yanxing Wang, Caixuan Liu, Chao Zhang, Wenyu Han, Xiaoyu Hong, Yifan Wang, Hong Qin, Shutian Wang, Qiaoyu Zhao et al. · 2020 · Science Advances
97. SARS-CoV-2 can induce brain and spine demyelinating lesions
    Luca Zanin, Giorgio Saraceno, Pier Paolo Panciani, Giulia Renisi, Liana Signorini, Karol Migliorati, Marco Maria Fontanella · 2020 · Acta Neurochirurgica
98. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
    Roosecelis B. Martines, Jana M. Ritter, Eduard Matkovic, Joy M. Gary, Brigid C. Bollweg, Hannah A. Bullock, Cynthia S. Goldsmith, Luciana M. Silva-Flannery, Josilene Nascimento Seixas, Sarah Reagan-Steiner et al. · 2020 · Emerging infectious diseases
99. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
    Oliver C. Grant, David Montgomery, Keigo Ito, Robert J. Woods · 2020 · Scientific Reports
100. Tackling COVID-19 with neutralizing monoclonal antibodies
     Davide Corti, Lisa A. Purcell, Gyorgy Snell, David Veesler · 2021 · Cell